NMDA Receptor Antagonists: Repositioning of Memantine as a Multitargeting Agent for Alzheimer's Therapy
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
NMDA Receptor Antagonists: Repositioning of Memantine as a Multitargeting Agent for Alzheimer's Therapy
Authors
Keywords
-
Journal
CURRENT PHARMACEUTICAL DESIGN
Volume 25, Issue 33, Pages 3506-3518
Publisher
Bentham Science Publishers Ltd.
Online
2019-10-12
DOI
10.2174/1381612825666191011102444
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Melatonin in Alzheimer’s Disease: A Latent Endogenous Regulator of Neurogenesis to Mitigate Alzheimer’s Neuropathology
- (2019) Md. Farhad Hossain et al. MOLECULAR NEUROBIOLOGY
- Emerging Signal Regulating Potential of Genistein Against Alzheimer’s Disease: A Promising Molecule of Interest
- (2019) Md. Sahab Uddin et al. Frontiers in Cell and Developmental Biology
- Cholinesterase Inhibitors for Alzheimer's Disease: Multitargeting Strategy Based on Anti-Alzheimer's Drugs Repositioning
- (2019) Md. Tanvir Kabir et al. CURRENT PHARMACEUTICAL DESIGN
- Emerging signal regulating potential of small molecule biflavonoids to combat neuropathological insults of Alzheimer's disease
- (2019) Md. Sahab Uddin et al. SCIENCE OF THE TOTAL ENVIRONMENT
- Peripheral and Central Effects of Memantine in a Mixed Preclinical Mice Model of Obesity and Familial Alzheimer’s Disease
- (2018) Miren Ettcheto et al. MOLECULAR NEUROBIOLOGY
- APOE and Alzheimer’s Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer’s Pathogenesis
- (2018) Md. Sahab Uddin et al. MOLECULAR NEUROBIOLOGY
- Autophagy and Alzheimer’s Disease: From Molecular Mechanisms to Therapeutic Implications
- (2018) Md. Sahab Uddin et al. Frontiers in Aging Neuroscience
- Retrospective Study on the Benefits of Combined Memantine and cholinEsterase inhibitor treatMent in AGEd Patients affected with Alzheimer's Disease: The MEMAGE Study
- (2018) Pietro Gareri et al. JOURNAL OF ALZHEIMERS DISEASE
- Is Memantine + Acetylcholinesterase Inhibitor Treatment Superior to Either Therapy Alone in Alzheimer's Disease?
- (2018) Francesco Mattace-Raso JOURNAL OF ALZHEIMERS DISEASE
- Mechanism of NMDA receptor channel block by MK-801 and memantine
- (2018) Xianqiang Song et al. NATURE
- Analyzing the chance of developing dementia among geriatric people: a cross-sectional pilot study in Bangladesh
- (2018) Md. Sahab Uddin et al. Psychogeriatrics
- Autophagic dysfunction in Alzheimer’s disease: Cellular and molecular mechanistic approaches to halt Alzheimer’s pathogenesis
- (2018) Md. Sahab Uddin et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Nootropic and Anti-Alzheimer’s Actions of Medicinal Plants: Molecular Insight into Therapeutic Potential to Alleviate Alzheimer’s Neuropathology
- (2018) Md. Sahab Uddin et al. MOLECULAR NEUROBIOLOGY
- Role of Glutamate and NMDA Receptors in Alzheimer’s Disease
- (2017) Rui Wang et al. JOURNAL OF ALZHEIMERS DISEASE
- Need for Better Diabetes Treatment: The Therapeutic Potential of NMDA Receptor Antagonists
- (2016) A. Welters et al. KLINISCHE PADIATRIE
- Dysfunction of NMDA receptors in Alzheimer’s disease
- (2016) Yan Zhang et al. NEUROLOGICAL SCIENCES
- Brain Insulin Resistance at the Crossroads of Metabolic and Cognitive Disorders in Humans
- (2016) Stephanie Kullmann et al. PHYSIOLOGICAL REVIEWS
- Elevated glucose and oligomeric β-amyloid disrupt synapses via a common pathway of aberrant protein S-nitrosylation
- (2016) Mohd Waseem Akhtar et al. Nature Communications
- Effects of dextromethorphan as add-on to sitagliptin on blood glucose and serum insulin concentrations in individuals with type 2 diabetes mellitus: a randomized, placebo-controlled, double-blinded, multiple crossover, single-dose clinical trial
- (2015) J. Marquard et al. DIABETES OBESITY & METABOLISM
- Alzheimer-associated A oligomers impact the central nervous system to induce peripheral metabolic deregulation
- (2015) J. R. Clarke et al. EMBO Molecular Medicine
- Characterization of pancreatic NMDA receptors as possible drug targets for diabetes treatment
- (2015) Jan Marquard et al. NATURE MEDICINE
- Beta cell glutamate receptor antagonists: novel oral antidiabetic drugs?
- (2015) Claes B Wollheim et al. NATURE MEDICINE
- Aberrant insulin signaling in Alzheimer's disease: current knowledge
- (2015) Gaurav Bedse et al. Frontiers in Neuroscience
- Alzheimer's disease
- (2015) Colin L. Masters et al. Nature Reviews Disease Primers
- Reciprocal disruption of neuronal signaling and Aβ production mediated by extrasynaptic NMDA receptors: a downward spiral
- (2014) Travis Rush et al. CELL AND TISSUE RESEARCH
- Inflammation, Defective Insulin Signaling, and Mitochondrial Dysfunction as Common Molecular Denominators Connecting Type 2 Diabetes to Alzheimer Disease
- (2014) F. G. De Felice et al. DIABETES
- New Melatonin–N,N-Dibenzyl(N-methyl)amine Hybrids: Potent Neurogenic Agents with Antioxidant, Cholinergic, and Neuroprotective Properties as Innovative Drugs for Alzheimer’s Disease
- (2014) Beatriz López-Iglesias et al. JOURNAL OF MEDICINAL CHEMISTRY
- Activity-Dependent Tau Protein Translocation to Excitatory Synapse Is Disrupted by Exposure to Amyloid-Beta Oligomers
- (2014) M. L. Frandemiche et al. JOURNAL OF NEUROSCIENCE
- Synergistic effects of amyloid-beta and wild-type human tau on dendritic spine loss in a floxed double transgenic model of Alzheimer's disease
- (2014) Meredith A. Chabrier et al. NEUROBIOLOGY OF DISEASE
- GRIN2Amutation and early-onset epileptic encephalopathy: personalized therapy with memantine
- (2014) Tyler Mark Pierson et al. Annals of Clinical and Translational Neurology
- Frequent and symmetric deposition of misfolded tau oligomers within presynaptic and postsynaptic terminals in Alzheimer’s disease
- (2014) Hwan-Ching Tai et al. Acta Neuropathologica Communications
- Effectiveness of Cholinesterase Inhibitors and Memantine for Treating Dementia: Evidence Review for a Clinical Practice Guideline
- (2013) Parminder Raina et al. ANNALS OF INTERNAL MEDICINE
- Combination Effects of ZSET1446/ST101 With Memantine on Cognitive Function and Extracellular Acetylcholine in the Hippocampus
- (2013) Yoshimasa Yamaguchi et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease
- (2013) Pierre Paoletti et al. NATURE REVIEWS NEUROSCIENCE
- Efficacy of Memantine, Donepezil, or Their Association in Moderate-Severe Alzheimer’s Disease: A Review of Clinical Trials
- (2013) Ivana Molino et al. TheScientificWorldJOURNAL
- NMDA receptor subunit composition determines beta-amyloid-induced neurodegeneration and synaptic loss
- (2013) C Tackenberg et al. Cell Death & Disease
- Galantamine potentiates the neuroprotective effect of memantine against NMDA-induced excitotoxicity
- (2013) João P. Lopes et al. Brain and Behavior
- Differential Pharmacological Effects on Brain Reactivity and Plasticity in Alzheimer’s Disease
- (2013) Anna-Katharine Brem et al. Frontiers in Psychiatry
- Electrophysiological changes precede morphological changes to frontal cortical pyramidal neurons in the rTg4510 mouse model of progressive tauopathy
- (2012) Johanna L. Crimins et al. ACTA NEUROPATHOLOGICA
- Combination therapy with galantamine and memantine improves behavioral and psychological symptoms of dementia (BPSD) in patients with early-onset Alzheimer’s disease
- (2012) Atsushi Hamuro AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Combining Galantamine and Memantine in Multitargeted, New Chemical Entities Potentially Useful in Alzheimer’s Disease
- (2012) Elena Simoni et al. JOURNAL OF MEDICINAL CHEMISTRY
- Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease
- (2012) Robert Howard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Distribution of Extrasynaptic NMDA Receptors on Neurons
- (2012) Ronald S. Petralia TheScientificWorldJOURNAL
- Lack of Evidence for the Efficacy of Memantine in Mild Alzheimer Disease
- (2011) Lon S. Schneider ARCHIVES OF NEUROLOGY
- Molecular basis of NMDA receptor functional diversity
- (2011) Pierre Paoletti EUROPEAN JOURNAL OF NEUROSCIENCE
- Synapses, NMDA receptor activity and neuronal Aβ production in Alzheimer’s disease
- (2011) Karim Bordji et al. REVIEWS IN THE NEUROSCIENCES
- Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial
- (2011) François Piette et al. Alzheimers Research & Therapy
- Amyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks
- (2010) Jorge J Palop et al. NATURE NEUROSCIENCE
- Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders
- (2010) Giles E. Hardingham et al. NATURE REVIEWS NEUROSCIENCE
- Tau Mislocalization to Dendritic Spines Mediates Synaptic Dysfunction Independently of Neurodegeneration
- (2010) Brian R. Hoover et al. NEURON
- Glutamate Receptor Ion Channels: Structure, Regulation, and Function
- (2010) S. F. Traynelis et al. PHARMACOLOGICAL REVIEWS
- Regulation of NMDA receptor Ca2+signalling and synaptic plasticity
- (2009) C. Geoffrey Lau et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Structural and functional changes in tau mutant mice neurons are not linked to the presence of NFTs
- (2009) A.B. Rocher et al. EXPERIMENTAL NEUROLOGY
- Picomolar Amyloid- Positively Modulates Synaptic Plasticity and Memory in Hippocampus
- (2009) D. Puzzo et al. JOURNAL OF NEUROSCIENCE
- Divergent Pathways Mediate Spine Alterations and Cell Death Induced by Amyloid- , Wild-Type Tau, and R406W Tau
- (2009) C. Tackenberg et al. JOURNAL OF NEUROSCIENCE
- Both NR2A and NR2B subunits of the NMDA receptor are critical for long-term potentiation and long-term depression in the lateral amygdala of horizontal slices of adult mice
- (2009) T. Muller et al. LEARNING & MEMORY
- Soluble Oligomers of Amyloid β Protein Facilitate Hippocampal Long-Term Depression by Disrupting Neuronal Glutamate Uptake
- (2009) Shaomin Li et al. NEURON
- Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior
- (2008) Dennis J. Selkoe BEHAVIOURAL BRAIN RESEARCH
- Structure-Function Implications in Alzheimers Disease: Effect of Aβ Oligomers at Central Synapses
- (2008) Waldo Cerpa et al. Current Alzheimer Research
- Neuronal viability is controlled by a functional relation between synaptic and extrasynaptic NMDA receptors
- (2008) F. Léveillé et al. FASEB JOURNAL
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now